Sildenafil Tablet, Film Coated
Product Images NDC 71335-2657

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71335-2657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 02)

Chemical structure diagram of the active ingredient Sildenafil, showing its molecular components and arrangement as depicted in the structural formula.*

FDA Label Image

4 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 05)

A line graph depicting change from baseline (meters) over weeks of study (Week 4, Week 8, Week 12) for four groups: Placebo, Sildenafil 20mg TID, Sildenafil 40mg TID, and Sildenafil 80mg TID. Data points include error bars showing variability.*

FDA Label Image

5 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 06)

A figure presenting a placebo-corrected change in 6-minute walk distance (meters) for Sildenafil 20 mg taken three times daily. The chart compares baseline walk distance, etiology, functional class, gender, age, mean pulmonary arterial pressure, and pulmonary vascular resistance index subgroups, showing the number of participants in placebo and Sildenafil groups and corresponding effect sizes with confidence intervals displayed as horizontal bars.*

FDA Label Image

Pi Logo (55aa9711 6df5 4516 Bf00 A1acf7f7a464 09)

FDA Label Image

Logo (55aa9711 6df5 4516 Bf00 A1acf7f7a464 10)

FDA Label Image

Figure-1 (Figure 1)

A chart showing fold change and 90% confidence intervals for area under the curve (AUC) and maximum concentration (Cmax) of sildenafil when coadministered with various interacting drugs including atorvastatin, azithromycin, bosentan, cimetidine, erythromycin, Maalox, oral contraceptives, ritonavir, and saquinavir. Recommendations for dose adjustment or coadministration are listed to the right.*

FDA Label Image

Figure-2 (Figure 2)

A bar chart illustrating fold change and 90% confidence intervals for various pharmacokinetic parameters (INR AUC, INR Cmax, BT, AUC, Cmax) of interacting drugs with sildenafil. The x-axis shows change relative to the interacting drug alone, centered at 1, and recommendations on dose adjustments or coadministration are noted for each drug.*

FDA Label Image

Figure-5 (Figure 5)

A survival curve graph illustrating the percentage of subjects without a clinically worsening event over time, comparing Sildenafil and Placebo groups. The x-axis represents days from randomization (0 to 112), and the y-axis shows the percentage without worsening (0 to 100%). Two curves are shown: a dotted line for Sildenafil and a solid line for Placebo, with the Sildenafil group maintaining a higher percentage over time.*

FDA Label Image

Label (Lbl713352657)

Sildenafil Tablets, USP 20 mg film-coated tablets in a package containing 10 tablets. The label shows the NDC 71335-2657-1 and states the product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Torrent Pharmaceuticals Ltd. Storage instructions and QR codes for patient information and package insert are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.